Progress in the development and acquisition of anticancer agents from marine sources

[11] Bresters Dorine, 2002, Proceedings of the American Association for Cancer Research Annual Meeting, V43, P925

[12] Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in human leukemia cells MOLT-4 [J]. LEUKEMIA, 2003, 17 (01) : 52 - 59

[13] Biomedical potential of marine natural products [J]. BIOSCIENCE, 1996, 46 (04) : 271 - 286

[14] CHAROENTUM C, 2001, P AN M AM SOC CLIN, V20, pB271

[15] Christian MC, 1997, SEMIN ONCOL, V24, P219

[16] Ciruelos E. M., 2002, P AN M AM SOC CLIN, V21, P106

[17] CIRUELOS ET, 2002, EUR J CANC

[18] COLOMBO N, 2001, P AN M AM SOC CLIN, V20, pA221

[19] DEARRUDA M, 1995, CANCER RES, V55, P3085

[20] DEMETRI GD, 2001, P AN M AM SOC CLIN, V20, pA352

[11] Bresters Dorine, 2002, Proceedings of the American Association for Cancer Research Annual Meeting, V43, P925

[12] Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in human leukemia cells MOLT-4 [J]. LEUKEMIA, 2003, 17 (01) : 52 - 59

[13] Biomedical potential of marine natural products [J]. BIOSCIENCE, 1996, 46 (04) : 271 - 286

[14] CHAROENTUM C, 2001, P AN M AM SOC CLIN, V20, pB271

[15] Christian MC, 1997, SEMIN ONCOL, V24, P219

[16] Ciruelos E. M., 2002, P AN M AM SOC CLIN, V21, P106

[17] CIRUELOS ET, 2002, EUR J CANC

[18] COLOMBO N, 2001, P AN M AM SOC CLIN, V20, pA221

[19] DEARRUDA M, 1995, CANCER RES, V55, P3085

[20] DEMETRI GD, 2001, P AN M AM SOC CLIN, V20, pA352